Germany's Bundestag passes a bill hiking drugmakers' patented-drug discount to 15.5%, aiming to cut €16.3B from 2027 health spending.
Germany’s federal parliament has voted to pass a bill designed to cut domestic healthcare spending that could negatively impact drugmakers, drawing sharp criticism from the …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
'Demands on all sides': German parliament approves health insurance cuts | Euractiv
Germany's health insurance austerity package becomes law
Germany’s revised pharma savings plan leaves industry facing €1bn hit | Euractiv
Boehringer-Deutschlandchef: Industrie wird de-priorisiert
Немецкий парламент одобрил реформу здравоохранения Германии, обязывающую фармкомпании вдвое увеличить скидки на лекарства
Gesundheitspolitik: Boehringer-Deutschlandchef: Industrie wird de-priorisiert
Parlamentul german adoptă un pachet legislativ controversat ce privește asigurările de sănătate
German pharma makes final push to derail health reform package | Euractiv
Bundestag beschließt umstrittenes Sparprogramm für den Gesundheitssektor
Pharmabranche sieht sich im Würgegriff von Nina Warken
Patients, hospitals and drugmakers will shoulder the savings burden
Backlash is brewing against a sweeping overhaul of Germany’s health insurance system as Eli Lilly and Boehringer Ingelheim slash…
The US has opened a Section 301 investigation into Germany's drug pricing system, escalating trade pressure as Berlin reviews…
Following much opposition from drugmakers, Germany has scrapped its plan to install a program that would have reduced the price…
Washington accuses Berlin of underpaying for innovative medicines. If the investigation confirms this, the United States could…
Germany’s parliament has approved sweeping cost-cutting measures for the statutory health insurance system, despite fierce…
